Medical Policy Announcements
Beginning January 1, 2014, the medical policy criteria for vein disease treatment will change. The medical policy titled; “Vein Disease Treatment (Endoluminal Radiofrequency Ablation, Endovenous Laser Ablation, Sclerotherapy or Ultrasound-guided Sclerotherapy” has been changed. The changes were published on page 4 in the Fall Provider News and will become effective on 01/01/2014. The criteria for radiofrequency ablation and endovenous laser ablation, as well as other treatments for vein disease will change. The documentation required will include detailed office notes and signed ultrasound reports. The criteria for sclerotherapy will not change, and will continue to require prior authorization.